Carbon dioxide;2-[chloromethyl(dimethyl)silyl]oxy-2-(4-methylcyclopenta-1,3-dien-1-yl)acetonitrile
C12H16ClNO3Si — CID 159841475
Data last refreshed: (MolForge compound catalog, from PubChem)
About Carbon dioxide;2-[chloromethyl(dimethyl)silyl]oxy-2-(4-methylcyclopenta-1,3-dien-1-yl)acetonitrile
Carbon dioxide;2-[chloromethyl(dimethyl)silyl]oxy-2-(4-methylcyclopenta-1,3-dien-1-yl)acetonitrile (PubChem CID 159841475) has the molecular formula C12H16ClNO3Si and a molecular weight of 285.80 g/mol. Its IUPAC name is carbon dioxide;2-[chloromethyl(dimethyl)silyl]oxy-2-(4-methylcyclopenta-1,3-dien-1-yl)acetonitrile.
Molecular Properties
| Compound Name | Carbon dioxide;2-[chloromethyl(dimethyl)silyl]oxy-2-(4-methylcyclopenta-1,3-dien-1-yl)acetonitrile |
|---|---|
| PubChem CID | 159841475 |
| Molecular Formula | C12H16ClNO3Si |
| Molecular Weight | 285.80 g/mol |
| Exact Mass | 285.06 |
| IUPAC Name | carbon dioxide;2-[chloromethyl(dimethyl)silyl]oxy-2-(4-methylcyclopenta-1,3-dien-1-yl)acetonitrile |
| SMILES | CC1=CC=C(C(C#N)O[Si](C)(C)CCl)C1.O=C=O |
| InChI | InChI=1S/C11H16ClNOSi.CO2/c1-9-4-5-10(6-9)11(7-13)14-15(2,3)8-12;2-1-3/h4-5,11H,6,8H2,1-3H3; |
| InChIKey | NOSPPKGBDQEPOY-UHFFFAOYSA-N |
| XLogP | 2.57 |
| TPSA | 67.16 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 18 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 285.80 |
| LogP ≤ 5 | 2.57 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 4 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'alkyl_halide', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159841475 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.